Singapore and Jiangsu expand cooperation in artificial intelligence, healthcare, biomedical sciences and innovation.
Singapore and China’s Jiangsu Province signed 23 agreements covering artificial intelligence (AI), healthcare, biomedical sciences, innovation and talent development at the 20th Singapore-Jiangsu Cooperation Council (SJCC) meeting in Suzhou on 10 November 2026. Co-chaired by Ms Indranee Rajah, Minister in the Prime Minister’s Office and Second Minister for Finance and National Development, and Mr Liu Xiaotao, Governor of Jiangsu Province, the meeting coincided with the council’s 20th anniversary and highlighted growing economic ties between Singapore and Jiangsu.
The meeting was attended by Mr Goh Pei Ming, Senior Minister of State for Home Affairs and Social and Family Development, Jiangsu Vice Governor Mr Ma Shiguang, and 130 government officials and business representatives from both sides.
Bilateral trade between Singapore and Jiangsu increased by 25 per cent year-on-year in the first half of 2026. Jiangsu also remained an important destination for Singapore investments, with more than 4,500 cumulative projects recorded in the province as of June 2026.
Singapore companies continued to expand their business operations in Jiangsu. SATS invested RMB312 million to increase its stake in Nanjing Weizhou Airline Food Corporation to 90 per cent, while CapitaLand partnered CHCC Capital to reposition an existing development in Zhenjiang under the CapitaMall brand.
Commenting on the council’s 20-year partnership, Ms Indranee said: “Over the past 20 years, the SJCC has brought our businesses and people closer together, while pioneering new areas of cooperation.”
She added that the partnership had continued to evolve alongside the changing needs of both economies, with Singapore companies turning opportunities in Jiangsu into concrete projects.
New initiatives announced at the meeting included the establishment of the Singapore Embodied AI Centre of Excellence at Suzhou Industrial Park by the Robotics Society of Singapore and China-Singapore Suzhou Industrial Park Development Group. The centre will support robotics and AI talent development and connect technological solutions with industrial applications.
In healthcare and biomedical sciences, A*STAR Partners’ Centre will work with Suzhou Industrial Park Biotech Development to facilitate clinical trials, scientific research and cross-border projects. The Singapore-China (Suzhou) Medical Centre was also unveiled to support joint medical research, innovation, professional training and exchanges between healthcare institutions.
Other agreements covered government exchanges, investment, green development, professional services and robotics applications. The initiatives will support further business, institutional and people-to-people exchanges between Singapore and Jiangsu.
Source: Enterprise Singapore
